Predictive models for maximum recommended therapeutic dose of antiretroviral drugs
From MaRDI portal
(Redirected from Publication:764174)
Recommendations
- QSAR prediction of HIV-1 protease inhibitory activities using docking derived molecular descriptors
- Aug-MIA-QSAR based strategy in bioactivity prediction of a series of flavonoid derivatives as HIV-1 inhibitors
- Prediction of IC\(_50\) values of 2-benzyloxybenzamide derivatives using multiple linear regression and artificial neural network methods
- Application to QSAR studies of 2-furylethylene derivatives
- Hierarchical Bayes model for predicting effectiveness of HIV combination therapies
Cites work
Cited in
(6)- scientific article; zbMATH DE number 1843094 (Why is no real title available?)
- Models for prediction of anti-HIV-1 activity of 5-Alkyl-2-alkylamino-6-(2,6-difluorophenylalkyl)-3,4-dihydropyrimidin-4\((3H)\)-ones using random forest, decision tree and moving average analysis
- The application of conformal prediction to the drug discovery process
- \textit{In vitro} transcriptomic prediction of hepatotoxicity for early drug discovery
- Accurate modeling of complex antitoxin effect of Quercetin based on neural networks
- Predicting inhibition constants of antimalarial drug compounds using support vector regression
This page was built for publication: Predictive models for maximum recommended therapeutic dose of antiretroviral drugs
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q764174)
